APUS

Conviction 20HealthcareScan · Thu, Jun 25, 2026

APUS$0.8940+0.45%

ResistanceSupportVol 14

Vol MA14 295.98K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Apimeds Pharmaceuticals US, Inc.PHARMACEUTICAL PREPARATIONSwww.apimedsus.com ↗

Price0.8940

Change+0.45%

Gap+7.40%

Rel volume68.65×

Avg volume219.18K

Avg $ vol208.19K

SMA 201.23

SMA 500.9903

SMA 2001.59

Price vs 50-9.72%

Price vs 200-43.89%

MA stackbearish

50/200 cross—

Supertrenddown · 1.58

RSI (14)40

MACD hist-0.07

MACD cross—

Stoch %K / %D10 / 7

ADX (14)46

+DI / −DI28 / 14

RSI divergence—

MACD divergence—

ATR %+26.11%

ADR %17.36%

52w high3.90

52w low0.0000

From 52w high-77.05%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width59.67%

%B0.04

Donchian pos9.50%

Donchian high1.55

Donchian low0.8251

AVWAP (52w high)2.29

vs AVWAP high-60.88%

AVWAP (52w low)2.29

vs AVWAP low-60.88%

OBV trendUp

Chaikin MF (20)-0.23

Today vs 20d68.65×

Avg vol (14d)295.98K

Avg vol (20d)219.18K

Avg $ vol (20d)208.19K

Market cap13.49M

RS 3m (vs SPY)-60.21%

RS 6m (vs SPY)-49.18%

RS line new highNo

Trend template0/8

Technical rank8.7

1 week-31.76%

1 month-37.04%

3 months-48.91%

6 months-46.79%

1 year-45.82%

YTD-46.31%

P/E-2.25

P/B0.11

P/S—

P/FCF-1.50

EPS-0.5500

Div yield—

ROE-4.74%

ROA-4.25%

Debt/Eq0.00

Current0.90

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-331.74%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value12.53M

Revenue—

Net income-35.06M

Gross profit—

Free cash flow-8.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out15.09M

Employees7

ListedFri, May 9, 2025

Free float6.85M

Float %54.4%

Short interest166.66K

Days to cover5.1d

Short volume59.2%

Squeeze score58 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank8.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.79

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APUS

All disclosures →

No recent disclosed trades by Congress in APUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APUS

No recent insider (Form 4) filings in APUS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in APUS

EDGAR →

No recent SEC filings on file for APUS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.